Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017.
Simon AthlinChrister LidmanAnders LundqvistPontus NauclerAnna C NilssonCarl SpindlerKristoffer StrålinJonas HedlundPublished in: Infectious diseases (London, England) (2017)
Based on expert group work, Swedish recommendations for the management of community-acquired pneumonia in adults are here updated. The management of sepsis-induced hypotension is addressed in detail, including monitoring and parenteral therapy. The importance of respiratory support in cases of acute respiratory failure is emphasized. Treatment with high-flow oxygen and non-invasive ventilation is recommended. The use of statins or steroids in general therapy is not found to be fully supported by evidence. In the management of pleural infection, new data show favourable effects of tissue plasminogen activator and deoxyribonuclease installation. Detailed recommendations for the vaccination of risk groups are afforded.
Keyphrases
- respiratory failure
- community acquired pneumonia
- mechanical ventilation
- cardiovascular disease
- intensive care unit
- liver failure
- acute kidney injury
- stem cells
- machine learning
- oxidative stress
- electronic health record
- acute respiratory distress syndrome
- cell therapy
- big data
- combination therapy
- diabetic rats
- respiratory tract
- breast cancer risk